@kantify

Kantify uses AI to discover breakthrough therapies that change patients' lives. Our next gen AI platform, Sapian, identifies novel targets and molecules

 Brussels, Belgium
kantify.com
Joined March 2016
  • Tweets715
  • Following433
  • Followers448
128Media
Lower key machine learning is the solution for Amazon! This is one of the hot topics we selected in our AI reads of the Week. Happy Reading! #Business #AI kantify.com/article/46
No! This photo is not AI edited: a heart-shaped sun ray appeared right during our last team photo!❤️ Meet below a team of people working every day with a lot of ❤️, talent, and AI - to accelerate the discovery of therapies for patients who need them the most.
2
3
99
We are releasing today a new AI driven analysis about a familiar drug, a go-to painkiller found in almost every medicine cabinet: Paracetamol (Acetaminophen).
2
1
1
326
In this new analysis, you’ll find not only the predicted targets but also some of the most striking insights revealed by Sapian. Sapian has predicted over 290 predicted proteins in the human body.
1
74
Amongst these proteins, the AI has identified groups linked to pain relief, oxidative stress or neurological effects. Ready to learn more? ➡️ kantify.com/insights/Sapian_… #pain #offtarget #polypharmacology
66
Our colleague, Dr. Rubal Ravinder, Biochemistry Machine Learning Engineer at Kantify, used our AI foundation model Sapian to take a deeper look at paracetamol and uncovered unexpected targets that could reshape how we understand its effects.
83
Join us to explore Innovation in Clinical Trials for Rare Diseases with renowned experts! 🗓️ Date: February 28, 2025 🕒 Time: 12:00 PM – 1:30 PM (CET) 🌐 Format: Online (registration: bit.ly/3PSLE3N) #RareDiseaseDay #RareDiseases #DREAMSProject #webinar
2
1
98
We are bringing the last touch to our new Behind The Pill release, where we'll share new Sapian predictions. We will focus on the unknown mechanisms of a drug that everyone knows, but is still largely misunderstood. ✉️Be the first to receive it kantify.com/about-us/newslet…
1
118
Hey Twitter, we are disclosing our biotech pipeline, and there is even a bonus for drug discovery experts. Cancer, Rare Cancers, Rare Neuromuscular disorders, Neurology and Ion Channels are some of our areas of focus.
1
3
4
301
more replies
Thank you to our fantastic partners who have trusted us. Together, we are pushing boundaries of drug discovery! @Xavier_Nissan @CanaudLab @guillaumebo6 @JorgeTwe @LUMC_Leiden @IGMM_Montpel @TeamPeptide @IStemFrance @MayaJeitany @Inserm @CNRS @pereraranjan @ArnaudMonteil
1
1
76
@HopkinsMedicine @QMiagoux @UAntwerpen @Nico_Maignan @NikSubramanian
1
96
So, what will we achieve in 2025? Well, we can't wait to tell you more 😉 In the meantime, we wish you the VERY BEST for this year to come.
Kantify@kantify2 Jan 2025
A new year is starting: hello, 2025! In 2024, we have: .made significant breakthroughs in cancer and rare diseases .discovered unknown mechanisms of diseases .taken giant steps in an fast timeline to find promising medicines .discovered the unknown life of medicines in the body
28
A new year is starting: hello, 2025! In 2024, we have: .made significant breakthroughs in cancer and rare diseases .discovered unknown mechanisms of diseases .taken giant steps in an fast timeline to find promising medicines .discovered the unknown life of medicines in the body
1
89
Kantify is excited to report its joint progress with @HopkinsMedicine on AI for prostate cancer drug discovery. While a traditional small molecule discovery screening requires testing 20,000 to 100,000 molecules to find 1 hit, we have tested only 5 molecules to validate... 4.
1
1
1
3
453
We are extremely proud of these results and are looking forward to helping patients! Congrats @pereraranjan , Menglang Yuan, Maxime Georges, @NikSubramanian @Nico_Maignan
1
1
41
Check more on the Kantify website⏩ kantify.com/insights/AI_pros…
35
Load more